X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (216) 216
index medicus (193) 193
cardiac & cardiovascular systems (179) 179
male (158) 158
female (151) 151
middle aged (137) 137
aged (125) 125
treatment outcome (103) 103
percutaneous coronary intervention (95) 95
clopidogrel (89) 89
cardiovascular (67) 67
ticlopidine - analogs & derivatives (66) 66
abridged index medicus (59) 59
risk factors (54) 54
stents (54) 54
aspirin (53) 53
heart attacks (52) 52
thrombosis (52) 52
care and treatment (49) 49
platelet aggregation inhibitors - therapeutic use (46) 46
peripheral vascular disease (45) 45
time factors (45) 45
platelet aggregation inhibitors - administration & dosage (44) 44
follow-up studies (42) 42
cardiology (41) 41
hematology (41) 41
mortality (41) 41
adult (40) 40
cardiac patients (40) 40
myocardial infarction (40) 40
acute coronary syndromes (37) 37
medical and health sciences (37) 37
medicin och hälsovetenskap (37) 37
prospective studies (37) 37
clinical medicine (33) 33
antiplatelet therapy (32) 32
klinisk medicin (32) 32
platelet reactivity (32) 32
angioplasty (31) 31
myocardial infarction - therapy (31) 31
therapy (31) 31
ticlopidine - administration & dosage (31) 31
transluminal angioplasty (31) 31
bleeding (30) 30
cardiology and cardiovascular medicine (30) 30
coronary vessels (30) 30
drug therapy (30) 30
internal medicine (30) 30
electrocardiography (29) 29
cardiac and cardiovascular systems (28) 28
cardiovascular disease (28) 28
drug therapy, combination (28) 28
kardiologi (28) 28
angioplasty, balloon, coronary (27) 27
anticoagulants (27) 27
stent thrombosis (27) 27
acute myocardial-infarction (26) 26
aged, 80 and over (26) 26
drug-eluting stents (26) 26
hemorrhage - chemically induced (26) 26
stroke (26) 26
ticlopidine - therapeutic use (26) 26
myocardial-infarction (25) 25
percutaneous coronary intervention - adverse effects (25) 25
risk (25) 25
implantation (24) 24
platelet function tests (24) 24
prognosis (24) 24
coronary artery disease (23) 23
heart attack (23) 23
intervention (23) 23
metaanalysis (23) 23
outcomes (23) 23
patients (23) 23
prasugrel (23) 23
reperfusion (23) 23
retrospective studies (23) 23
coronary angiography (22) 22
predictive value of tests (22) 22
stent (22) 22
atrial fibrillation (21) 21
double-blind method (21) 21
dual antiplatelet therapy (21) 21
percutaneous coronary intervention - methods (21) 21
platelet aggregation inhibitors - adverse effects (21) 21
risk assessment (21) 21
blood platelets (20) 20
coronary heart disease (20) 20
studies (20) 20
task-force (20) 20
ticagrelor (20) 20
patient outcomes (19) 19
platelet aggregation - drug effects (19) 19
clinical trials (18) 18
dose-response relationship, drug (18) 18
impact (18) 18
medical research (18) 18
analysis (17) 17
anticoagulants - administration & dosage (17) 17
anticoagulants - therapeutic use (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 08/2016, Volume 116, Issue 2, pp. 369 - 378
SummaryPRIVATE-ATLANTIC (P2Y12 Receptor Inhibition with VASP Testing using Elisa kit during the ATLANTIC study) is a pre-specified substudy of the randomised,... 
STEMI | Morphine | Ticagrelor | Platelet reactivity | PCI
Journal Article
Heart, ISSN 1355-6037, 02/2011, Volume 97, Issue 3, p. 263
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 16, pp. 1513 - 1524
In this trial, dabigatran plus a P2Y 12 inhibitor was compared with warfarin plus a P2Y 12 inhibitor and aspirin after PCI in patients with atrial... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | HEART-DISEASE | MYOCARDIAL-INFARCTION | ORAL ANTICOAGULATION | 2011 ACCF/AHA/SCAI GUIDELINE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | TRIPLE THERAPY | ANTIPLATELET THERAPY | CONSENSUS DOCUMENT | Dabigatran - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Warfarin - adverse effects | Male | Risk | Dabigatran - therapeutic use | Incidence | Warfarin - therapeutic use | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Therapy, Combination - adverse effects | Adenosine - adverse effects | Adenosine - therapeutic use | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Purinergic P2Y Receptor Antagonists - therapeutic use | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention | Warfarin | Atrial fibrillation | Dosage and administration | Research | Thromboembolism | Hemorrhage | Health aspects | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Embolisms | Preventive medicine | Thrombosis | Bleeding | Embolism | Fibrillation | Cardiology | Drug therapy | Drug dosages | Geriatrics | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Blood Coagulation & Fibrinolysis, ISSN 0957-5235, 09/2019, Volume 30, Issue 6, pp. 263 - 269
High on-treatment platelet reactivity (HPR) on P2Y12-inhibitors in patients treated with dual antiplatelet therapy is strongly associated with adverse... 
Journal Article
Revista Espanola de Cardiologia, ISSN 0300-8932, 06/2016, Volume 69, Issue 6, p. 608
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2013, Volume 369, Issue 23, pp. 2207 - 2217
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 62, Issue 24, pp. 2261 - 2273
Journal Article